Takaaki Akasaka

Type II Topoisomerase Mutations in Fluoroquinolone-Resistant Clinical Strains of <i>Pseudomonas aeruginosa</i> Isolated in 1998 and 1999: Role of Target Enzyme in Mechanism of Fluoroquinolone Resistance

Takaaki Akasaka, Mayumi Tanaka, Akihito Yamaguchi et al. · Antimicrobial Agents and Chemotherapy · 2001 · 182 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Antibacterial Activities and Inhibitory Effects of Sitafloxacin (DU-6859a) and Its Optical Isomers against Type II Topoisomerases

Takaaki Akasaka, Seiko Kurosaka, Yoko Uchida et al. · Antimicrobial Agents and Chemotherapy · 1998 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

InVitro and In Vivo Antibacterial Activities of DK-507k, aNovelFluoroquinolone

Tsuyoshi Otani, Mayumi Tanaka, Emi Ito et al. · Antimicrobial Agents and Chemotherapy · 2003 · 31 citations · Full text

Life Sciences, Microbiology, Pharmacology +13

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study

Haruhito A. Uchida, Hirofumi Nakajima, Masami Hashimoto et al. · Advances in Therapy · 2022 · 29 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Role of the conserved quartets of residues located in the N- and C-terminal halves of the transposon Tn10-encoded metal-tetracycline/hydrogen ion antiporter of Escherichia coli

Akihito Yamaguchi, Takaaki Akasaka, Tomomi Kimura et al. · Biochemistry · 1993 · 27 citations

Life Sciences, Biochemistry, Microbiology +10